This contribution will be utilised to fund Cancer Research at the University of Malta, aimed at advancing the country’s understanding of cancer and improving current treatment options.
The announcement comes as part of the ALIVE Charity Foundation's commitment to supporting initiatives that contribute to the prevention, detection, and treatment of cancer.
"We are proud to make this donation on World Cancer Day, a day that resonates deeply with our mission to combat this devastating disease. The funds will go towards supporting ground-breaking research projects at the University of Malta, contributing to advancements in cancer treatment and care," said Nicky Camilleri, Chairperson of the ALIVE Charity Foundation.
Since its inception in 2013, the Foundation has donated over €820,000 for various cancer research projects. The ALIVE Charity Foundation thanked all its fund-raising partners, particularly Tum Invest, La Roche Posay, Garmin Malta, Falzon Group, Empav Engineering and Cisk 0.0, for their support, playing a pivotal role in the success of the Foundation's 2023 campaign.